PCI PHARMA SERVICES
PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.
Our core services support each stage of the product lifecycle, including drug development, clinical trial supply, commercial launch and ongoing commercial supply. We partner with clients in providing innovative technologies, flexible solutions, and an integrated supply network supporting lifesaving medicines destined to over 100 countries around the world.
We support clients with a dedication to providing the industry’s leading experience, exemplified in our operational flexibility, delivery, and commitment to safety, supported by industry leading technologies and an exemplary quality and regulatory record. This has allowed us to be the partner of choice for leading pharmaceutical companies around the world, operating as a seamless extension of their business.
VIDEOS
CLINICAL TRIAL SERVICES
PCI provides a comprehensive service at each stage of the product lifecycle for a wide range of dosage forms, in full compliance with GMP regulatory standards for both highly potent and non-potent drug products.
With unrivalled experience in packaging and labeling, we combine knowledge, expertise, innovative technologies and a dedicated team of specialists to ensure the highest quality standard of clinical supplies.
Leveraging over 20 years of experience in injectable packaging, PCI supports multiple delivery forms from Phase I through commercialization.
As pharmaceutical companies seek to streamline early phase development to establish proof of concept quickly and efficiently, PCI’s Speed to StudyTM services are designed to manoeuvre complex trial designs with maximized flexibility and speed.
PCI offers over 30 years’ experience in the storage and distribution of clinical trial materials, effectively storing and distributing thousands of patient kits to over 100 countries world-wide.
PCI offers the expertise to assist clients with overcoming hurdles experienced during the clinical lifecycle, with a collaborative approach to solving challenges that may arise.
CONTACT INFORMATION
PCI Pharma Services
3001 Red Lion Road
Philidelphia, PA 19114
UNITED STATES
Phone: 908-210-4029
Fax: 215-613-3601
Contact: Ed Malatesta
BROCHURES
- Packaging Design And Development Services
- Frozen Packaging Solutions
- pci | bridge: Real-Time Supply Chain Information
- Scalable Manufacturing Of Sterile Drug Products
- Advancing Your Product From Development To Commercialization
- Expedite Your Clinical Study
- Get Products Through Development, Commercialization, And Beyond
- An Introductory Guide To Clinical EU Qualified Person (QP) Services
- Dual Sourcing: Mitigating Risk In Your Supply Chain
- SMART First Human Dose (FHD)
FEATURED ARTICLES
- Development And Manufacture Of A Highly Potent OSD Product
- Driving Precision, Agility, And Partnership In Drug Development
- Parenteral Manufacturing And Packaging Trends
- Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch
- Driving Sterile Innovation At Scale
- Part Of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition Of Ajinomoto Althea, Enhancing U.S. Drug Product Manufacturing For Aseptic Filling Of Prefilled Syringes & Cartridges
- PCI Pharma Services To Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
- PCI Pharma Services And ChiRhoClin Partner To Prevent Shortage Of Critical Orphan Pancreatic Drug
- PCI Pharma Services Invests Over $365 Million In EU, US Facilities For Clinical And Commercial Supply Of Advanced Drug Delivery And Drug-Device Combination Products
- PCI Pharma Services' Bedford, New Hampshire Location Successfully Completes International Coalition Of Medicines Regulatory Authorities Inspection
- Construction And Validation Activities At The PCI Pharma Services Bedford, NH Campus Will Conclude Later This Year, With GMP Production Commencing In Early 2025
- CDMO Support: Success In Early-Phase Drug Product Development
- Creating A Sustainable Pharmaceutical Supply Chain
- Advancing Your API To First Human Dose Trials More Efficiently
- Advantages Of Robotic Aseptic Processing
- Outsourcing Your Highly Potent Oncology Drug Product
- Controlled Substances In Clinical Trials
- Addressing Rare Disease Drug Product Manufacturing Challenges
- Quality Assured: Bringing Life-Changing Therapies To Patients
- Highly Potent, Perfectly Packaged